156 related articles for article (PubMed ID: 24313282)
1. Core-shell nanocarriers for cancer therapy. Part I: biologically oriented design rules.
d'Angelo I; Conte C; Miro A; Quaglia F; Ungaro F
Expert Opin Drug Deliv; 2014 Feb; 11(2):283-97. PubMed ID: 24313282
[TBL] [Abstract][Full Text] [Related]
2. Organic nanocarriers for cancer drug delivery.
López-Dávila V; Seifalian AM; Loizidou M
Curr Opin Pharmacol; 2012 Aug; 12(4):414-9. PubMed ID: 22465543
[TBL] [Abstract][Full Text] [Related]
3. Tumor-targeting glycol chitosan nanocarriers: overcoming the challenges posed by chemotherapeutics.
Choi Y; Lim S; Yoon HY; Kim BS; Kwon IC; Kim K
Expert Opin Drug Deliv; 2019 Aug; 16(8):835-846. PubMed ID: 31343904
[No Abstract] [Full Text] [Related]
4. Alteration of tumor microenvironment for improved delivery and intratumor distribution of nanocarriers.
Ishida T; Kiwada H
Biol Pharm Bull; 2013; 36(5):692-7. PubMed ID: 23649327
[TBL] [Abstract][Full Text] [Related]
5. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
[TBL] [Abstract][Full Text] [Related]
6. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
7. Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer.
Kumar L; Baldi A; Verma S; Utreja P
Pharm Nanotechnol; 2018; 6(2):94-110. PubMed ID: 29866028
[TBL] [Abstract][Full Text] [Related]
8. Nanocarriers for the Effective Treatment of Cervical Cancer: Research Advancements and Patent Analysis.
Pathak K; Akhtar N
Recent Pat Drug Deliv Formul; 2018; 12(2):93-109. PubMed ID: 29611489
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution of lipid nanoparticles: a comparative study of pulmonary versus intravenous administration in rats.
Videira MA; Santos AC; Botelho MF
Curr Radiopharm; 2012 Apr; 5(2):158-65. PubMed ID: 22280113
[TBL] [Abstract][Full Text] [Related]
10. Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy.
Jeong K; Kang CS; Kim Y; Lee YD; Kwon IC; Kim S
Cancer Lett; 2016 Apr; 374(1):31-43. PubMed ID: 26854717
[TBL] [Abstract][Full Text] [Related]
11. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
12. Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
Torchilin VP
AAPS J; 2007 May; 9(2):E128-47. PubMed ID: 17614355
[TBL] [Abstract][Full Text] [Related]
13. Hydrophobic ion pairing as a strategy to improve drug encapsulation into lipid nanocarriers for the cancer treatment.
Oliveira MS; Goulart GCA; Ferreira LAM; Carneiro G
Expert Opin Drug Deliv; 2017 Aug; 14(8):983-995. PubMed ID: 27892713
[TBL] [Abstract][Full Text] [Related]
14. Nanocarriers in Improving Chemotherapy of Multidrug Resistant Tumors: Key Developments and Perspectives.
Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV
Curr Pharm Des; 2017; 23(22):3301-3308. PubMed ID: 28403792
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery.
Battaglia L; Gallarate M
Expert Opin Drug Deliv; 2012 May; 9(5):497-508. PubMed ID: 22439808
[TBL] [Abstract][Full Text] [Related]
16. Cellulose-based Nanocarriers as Platforms for Cancer Therapy.
Meng LY; Wang B; Ma MG; Zhu JF
Curr Pharm Des; 2017; 23(35):5292-5300. PubMed ID: 29086678
[TBL] [Abstract][Full Text] [Related]
17. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
[TBL] [Abstract][Full Text] [Related]
18. Nanocarriers: a tool to overcome biological barriers in siRNA delivery.
Kumari A; Kumar V; Yadav SK
Expert Opin Biol Ther; 2011 Oct; 11(10):1327-39. PubMed ID: 21682658
[TBL] [Abstract][Full Text] [Related]
19. Editorial: Polymeric Nanocarriers as Robust Platforms for Cancer Therapy.
Elzoghby AO
Curr Pharm Des; 2017; 23(35):5211-5212. PubMed ID: 29110600
[No Abstract] [Full Text] [Related]
20. Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer.
Liu Y; Xu CF; Iqbal S; Yang XZ; Wang J
Adv Drug Deliv Rev; 2017 Jun; 115():98-114. PubMed ID: 28396204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
